Mechanisms of cellular, synaptic and circuit dysfunction in Kcnc1-related epileptic encephalopathy

Kcnc1相关癫痫性脑病的细胞、突触和回路功能障碍的机制

基本信息

  • 批准号:
    10424981
  • 负责人:
  • 金额:
    $ 6.72万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-06-01 至 2025-05-31
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY I am applying for this NRSA postdoctoral fellowship with the long-term career goal of becoming an independent investigator capable of leading a highly productive research lab in the field of neuroscience. Under the guidance of Dr. Ethan Goldberg and Dr. Doug Coulter, this mentored fellowship will provide me the conceptual and hands-on training required to achieve my goal and thrive in the scientific enterprise. Pathogenic variants in the gene KCNC1, which encodes the voltage-gated potassium channel subunit Kv3.1, lead to severe neurological disease including epilepsy. While most patient-derived variants are loss-of- function, the precise mechanisms by which impaired Kv3.1 function alters individual neuron physiology and neural circuit function to result in spontaneous seizures are unclear. Kv3.1 is prominently expressed in parvalbumin-positive fast-spiking inhibitory interneurons (PV-IN) in various subcellular regions including the dendrites, soma, axon, and synaptic terminal where it critically contributes to reliable high-frequency action potential generation and propagation. Because PV-INs critically contribute to network dynamics and constrain excitability of nearby excitatory pyramidal neurons in cortical circuits, we hypothesize that Kv3.1 dysfunction impairs PV-IN high-frequency action potential generation and propagation, disinhibits pyramidal neurons, and contributes to aberrant network excitability to drive abnormal behavior and seizures. Therefore, the overarching objective of this study is to determine the effect of mutant Kv3.1 on PV-IN physiology as a potential major contributor to pathogenesis of KCNC1-related epilepsy. In aim 1, I will collect patch-clamp electrophysiology recordings of somatic and axonal potassium channel function and neuronal excitability in PV-INs from a novel mouse model of KCNC1 epilepsy which harbors the epileptic encephalopathy patient-derived p.A421V variant. Given the substantially reduced channel activity observed in the p.A421V variant, and that Kv3 currents are necessary for fast-spiking physiology, I anticipate that PV-INs from the mouse model of KCNC1 epileptic encephalopathy will exhibit impaired action potential generation at the soma, and unreliable propagation through the axon. In aim 2, I will interrogate deficits in inhibitory synaptic transmission in response to mutant Kv3.1 expression using multiple (6-8) simultaneous recordings of synaptically-connected PV-INs and pyramidal neurons in cortical microcircuits. Lastly, in aim 3 I will corroborate my in vitro findings in the in vivo context through calcium-imaging of neuronal activity in awake, behaving mice. To relate neuronal activity to relevant behavior, I will examine the excitability of both cortical pyramidal neurons and PV-INs in response to sensory stimulation by whisker deflection and test the hypothesis that altered Kv3.1 function in PV-INs compromises network inhibition in vivo. Overall, completion of the aims described in this mentored fellowship will provide significant insight into the mechanisms of epilepsy in KCNC1-related disorders and deeper understanding of the contribution of Kv3 channels to PV-IN physiology in general.
项目概要 我正在申请 NRSA 博士后奖学金,其长期职业目标是成为一名 独立研究员,有能力领导神经科学领域高效的研究实验室。在下面 在 Ethan Goldberg 博士和 Doug Coulter 博士的指导下,这个指导奖学金将为我提供 实现我的目标并在科学事业中蓬勃发展所需的概念和实践培训。 KCNC1 基因的致病性变异,该基因编码电压门控钾通道亚基 Kv3.1,导致严重的神经系统疾病,包括癫痫。虽然大多数源自患者的变异都丢失了 功能,受损的 Kv3.1 功能改变个体神经元生理学的精确机制以及 导致自发性癫痫发作的神经回路功能尚不清楚。 Kv3.1 突出地表达于 小清蛋白阳性快速尖峰抑制性中间神经元(PV-IN)位于各个亚细胞区域,包括 树突、体细胞、轴突和突触末梢,它对可靠的高频动作做出了至关重要的贡献 潜在的产生和传播。因为 PV-IN 对网络动态做出了至关重要的贡献并限制了 皮质回路中附近兴奋性锥体神经元的兴奋性,我们假设 Kv3.1 功能障碍 损害 PV-IN 高频动作电位的产生和传播,抑制锥体神经元,以及 导致异常的网络兴奋性,从而导致异常行为和癫痫发作。因此,总体 本研究的目的是确定突变体 Kv3.1 对 PV-IN 生理学的影响作为潜在的主要 KCNC1 相关癫痫发病机制的贡献者。在目标 1 中,我将收集膜片钳电生理学信息 记录体细胞和轴突钾通道功能以及 PV-IN 中的神经元兴奋性 KCNC1 癫痫小鼠模型,含有癫痫性脑病患者衍生的 p.A421V 变体。 鉴于 p.A421V 变体中观察到的通道活动大幅减少,并且 Kv3 电流为 对于快速峰值生理学来说是必要的,我预计来自 KCNC1 癫痫小鼠模型的 PV-IN 脑病将表现出体细胞动作电位产生受损,并且通过不可靠的传播 轴突。在目标 2 中,我将探讨针对突变体 Kv3.1 的抑制性突触传递缺陷 使用突触连接的 PV-IN 和锥体的多个 (6-8) 同时记录进行表达 皮质微电路中的神经元。最后,在目标 3 中,我将在体内证实我的体外发现 通过对清醒、行为正常的小鼠的神经元活动进行钙成像。将神经元活动与相关的 行为,我将检查皮质锥体神经元和 PV-IN 对感觉的反应的兴奋性 通过晶须偏转进行刺激并测试改变 PV-IN 中 Kv3.1 功能的假设 体内网络抑制。总体而言,完成本指导奖学金中描述的目标将提供 对 KCNC1 相关疾病的癫痫机制有深入的了解,并对 KCNC1 相关疾病的癫痫机制有更深入的了解 Kv3 通道对 PV-IN 生理学的总体贡献。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Eric Ryan Wengert其他文献

Eric Ryan Wengert的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Eric Ryan Wengert', 18)}}的其他基金

Mechanisms of cellular, synaptic and circuit dysfunction in Kcnc1-related epileptic encephalopathy
Kcnc1相关癫痫性脑病的细胞、突触和回路功能障碍的机制
  • 批准号:
    10640847
  • 财政年份:
    2022
  • 资助金额:
    $ 6.72万
  • 项目类别:
Depolarization block of inhibitory neurons impacts neuronal function in epileptic encephalopathy
抑制性神经元的去极化阻滞影响癫痫性脑病的神经元功能
  • 批准号:
    10020197
  • 财政年份:
    2019
  • 资助金额:
    $ 6.72万
  • 项目类别:
Depolarization block of inhibitory neurons impacts neuronal function in epileptic encephalopathy
抑制性神经元的去极化阻滞影响癫痫性脑病的神经元功能
  • 批准号:
    9911626
  • 财政年份:
    2019
  • 资助金额:
    $ 6.72万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 6.72万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 6.72万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 6.72万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 6.72万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 6.72万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 6.72万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 6.72万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 6.72万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 6.72万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 6.72万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了